Investigational Vaccine for the Prevention of Disseminated Tuberculosis in HIV Infected People

Clinical trial NCT00052195 · COMPLETED

Trial details

NCT number: NCT00052195
Sponsor: Dartmouth-Hitchcock Medical Center
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Tuberculosis HIV Infections

Start date: 2001-09-01
Primary completion: 2008-12-01
Enrollment: 1975

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.